Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

(-)-(2R)-3-(2-hydroxymethylindanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate

EU orphan designation number: EU/3/08/560   
Active ingredient: (-)-(2R)-3-(2-hydroxymethylindanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate
Indication: Treatment of moderate and severe closed traumatic brain injury
Sponsor: KeyNeurotek Pharmaceuticals AG
Zenit-Technology Park Leipzigerstr. 44, D-39120 Magdeburg, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/09/2008 Centralised Orphan - Designation EMEA/OD/007/07 (2008)5021 of 05/09/2008